Envista (NYSE:NVST) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Envista (NYSE:NVST) issued its earnings results on Wednesday. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01, Zacks reports. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. Envista updated its FY 2025 guidance to 0.950-1.050 EPS.

Envista Stock Up 2.2 %

Shares of NVST stock traded up $0.45 during trading hours on Wednesday, reaching $20.58. 4,921,988 shares of the company’s stock were exchanged, compared to its average volume of 2,076,956. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The company has a market cap of $3.54 billion, a price-to-earnings ratio of -2.65, a P/E/G ratio of 1.82 and a beta of 1.34. Envista has a fifty-two week low of $15.15 and a fifty-two week high of $24.79. The stock’s 50 day moving average is $20.00 and its 200-day moving average is $19.09.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on NVST shares. Stifel Nicolaus lifted their price target on shares of Envista from $18.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a report on Thursday, October 31st. Piper Sandler raised their price target on Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a research note on Monday. Leerink Partners raised shares of Envista from an “underperform” rating to a “market perform” rating and upped their price objective for the stock from $16.00 to $23.00 in a research note on Thursday, October 31st. Finally, Robert W. Baird raised their target price on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $20.21.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.